Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered Extracellular Vesicles for Cancer Therapy
Xu Zhang, Hongbo Zhang, Jianmei Gu, et al.
Advanced Materials (2021) Vol. 33, Iss. 14
Open Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Zhijie Weng, Bowen Zhang, Chenzhou Wu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 254
Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 193
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
Jiahui Zhang, Cheng Ji, Hongbo Zhang, et al.
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 173
Exosome engineering in cell therapy and drug delivery
Somayeh Sadeghi, Fahimeh Ramezani Tehrani, Safa Tahmasebi, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 145-169
Open Access | Times Cited: 159
Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine
Maria Antonietta Di Bella
Biology (2022) Vol. 11, Iss. 6, pp. 804-804
Open Access | Times Cited: 151
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 104
Extracellular vesicles: a rising star for therapeutics and drug delivery
Shuang Du, Yucheng Guan, Aihua Xie, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 95
Specific anti‐glioma targeted‐delivery strategy of engineered small extracellular vesicles dual‐functionalised by Angiopep‐2 and TAT peptides
Zhanchi Zhu, Yuanxin Zhai, Ying Hao, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 86
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 81
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Yang Qiu-rong, Jing Xu, Jianmei Gu, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 79
Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease Treatment
Fang Xu, Yi Wu, Qianyu Yang, et al.
Advanced Materials (2022) Vol. 34, Iss. 49
Closed Access | Times Cited: 78
Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine
Min Li, Fang Fang, Meng Sun, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4879-4903
Open Access | Times Cited: 73
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer
Vivek P. Chavda, Lakshmi Vineela Nalla, Pankti C. Balar, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1023-1023
Open Access | Times Cited: 52
Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy
Tianchuan Zhu, Zhenxing Chen, Guanmin Jiang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16770-16786
Closed Access | Times Cited: 49
Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes
Jingwen Xiong, Hao Chi, Guanhu Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 36
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 27
Engineering and Targeting Neutrophils for Cancer Therapy
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 25
Bio‐Inspired Porous Microneedles Dwelled Stem Cells for Diabetic Wound Treatment
Lu Fan, Xiaoxuan Zhang, Lianzhou Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 28
Closed Access | Times Cited: 23
Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics
Chun Liu, Negar Yazdani, Corey S. Moran, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 18-45
Open Access | Times Cited: 21
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles
Xiao Cheng, Brian S. Henick, Ke Cheng
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6748-6765
Closed Access | Times Cited: 17
The role and application of small extracellular vesicles in gastric cancer
Hao Wu, Mengdi Fu, Jin Liu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 81
Suction‐Cup‐Inspired Adhesive Micromotors for Drug Delivery
Lijun Cai, Cheng Zhao, Hanxu Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 70
Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine
Zhijin Fan, Cheng Jiang, Yichao Wang, et al.
Nanoscale Horizons (2022) Vol. 7, Iss. 7, pp. 682-714
Closed Access | Times Cited: 62
Page 1 - Next Page

Scroll to top